Dear Editor, The recent article by Westekemper et al. was highly interesting [1] . Nemorosone may exert a number of anti-neoplastic effects in a number of systemic malignancies.
Nemorosone acts on estrogen receptors α, and thereby attenuates tumor growth in breast malignancies. Nemorosone administration results in attenuated expression of pERK1/2 and pAkt [2] . The resulting effect is decreased intra-tumoral apoptosis in G0/G1 phase blockage.
Nemorosone is also effective in the management of gastro-intestinal malignancies. For instance, it activates the unfolded protein response (UPR) network in pancreatic malignancies and thereby accentuates tumor apoptosis in these cancers [3] . UPR-mediated apoptosis is regulated primarily by DNA damage inducible transcript 3. Simultaneously, the mitochondrial membrane potential is reduced. A simultaneous accentuation of cytochrome c release is seen. Nemorosone also exerts anti-proliferative effects in leukemias by altering hematopoiesis. It mediates these effects in part by modulating Akt/PKB function [4] . The key advantage of nemorosone is that it helps overcome chemo-resistance in leukemias. A simultaneous decline in cyclins A and c-Myb is noticed. Down-regulation of p38 MAPK also accompanies nemorosone administration in leukemia's.
Nemorosone is also effective in inhibiting growth in androgen-dependent prostate malignancies. For instance, 7-epi-nemorosone targets MEK1/2 and thereby induces cytotoxic effects in prostate carcinomas [5] . Nemorosone administration results in a decline in S phase cells and an increase in G0/G1 phase cells. CDK 4/6 is also downregulated. Attenuation of PSA levels occurs subsequently, resulting in better tumor growth control. Nemorosone is also effective in the management of intracranial tumors such as neuroblastomas. It mediates these anti-neoplastic effects by down-regulating N-myc levels [6] . An increase in the activity of caspase-3, and simultaneous inhibition of Akt/PKB also contributes to these anti-neoplastic effects.
The above examples clearly illustrate the effectiveness of nemorosone in attenuating tumor growth in a number of systemic malignancies.
